一氧化氮与门静脉高压症_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

管洪庚 , 综述 , 陈易人 , 审校

Corresponding author：

Keywords：

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 管洪庚,综述,陈易人,审校. 一氧化氮与门静脉高压症. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 1998, 5(3): 185-187. doi: Copy

1.	梅小君，顾正中.一氧化氮对脑血流的调节.生理科学进展， 1995； 26(1)∶35.
2.	Gadano AC, Sogni P, Yang S, et al. Endothelial calciumcalmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivily of portal hypertensive rats. J Hepatol, 1997; 26(3)∶678.
3.	Cahill PA, Foster C, Redmond EM, et al. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology, 1995; 22(2)∶598.
4.	Pilette C, Moreau R, Sogni P, et al. Haemodynamic and hormonal responses to longterm inhibition of nitric oxide synthesis in rats with portal hypertension. Eur J Pharmacol, 1996; 312(1)∶63.
5.	Garc J, Atucha NM, Groszmann RJ. Renal response to methoxamine in portal hypertensive rats: role of prostaglandins and nitric oxide. J Hepatol, 1996; 25(2)∶206.
6.	Michielsen PP, Boeckxstaens GE, Sys SU, et al. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in longterm portal vein ligated rats. J Hepatol. 1995; 23(3)∶341.
7.	Pizcuta P, Pique JM, Fernandez M, et al. Modulation of the hyperdynamic circulation of cirrhosis rats by nitric oxide inhibition. Gastroenterology, 1992; 103(2)∶1909.
8.	Pilette C, Kirstetter P, Sogni P, et al. Dosedependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hyportension in conscious rats. J Gastroenterol Hepatol, 1996; 11(1)∶1.
9.	Sieber CC, Lee FY, Groszmann RJ. Longterm octreotide treatment prevents hyporeactivity in portal hypertensive rats. Hepatology, 1996; 23(5)∶1218.
10.	Cawley T, Breslin E, Geraghty J, et al. Investigations of the function of the vascular endothelium in portal hypertensive rats. Pharmacology, 1995; 51(6)∶381.
11.	Hori N, Takahashi H, Okanoue T, et al. Augmented endogenous nitric oxide production in partial portal vein ligated rats. Clin Exp Pharmacol Physiol, 1995; 22(8)∶506.
12.	Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vascular in mesenteric vessels of portal hypertensive rats. Gastroenterology, 1992; 103(1)∶235.
13.	Karatapanis S, McCornick PA, Kaked S, et al. Alteration in vascular reactivity in isolated aortic rings from portal veinconstricted rats. Hepatology, 1994; 20(6)∶1516.
14.	Cahill PA, Redmond EM, Hodges R, et al. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol, 1996; 25(3)∶370.
15.	Wu Y, Burns RC, Sitzmann JV. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. Hepatology, 1993; 18(6)∶1416.
16.	Sogni P, Moreau R, Ohsuga M, et al. Evidence for normal nitric oxidemediated vasodilator tone in conscious rats with cirrhosis. Hepatology, 1992; 16(4)∶980.
17.	Iwata F, Joh T, Kawai T, et al. Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats. Am J Physiol, 1992; 263(4)∶G149.
18.	Mosca P, Lee FY, Kaumann AJ, et al. Pharmacology of portalsystemic collaterals in portal hypertensive rats: role of endothelium. Am J Physiol, 1992; 263(4 pt 1)∶G544.
19.	Lee FY, Wang SS, Tsai YT, et al. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats. J Hepatol, 1997; 26(3)∶687.
20.	Michielsen PP, Pelckmans A. Haemodynamic changes in portal hypertension: new insights in the pathogenesis and clinical implications. Acta Gastroenterol Belg, 1994; 57(2)∶194.
21.	Lee FY, Colombato LA, Albillos A, et al. Administration of N omeganitroLarginine ameliorates portalsystemic shunting in portalhypertensive rats. Gastroenterology, 1993; 105(5)∶1464.
22.	Martin PY, Schrier RW. Pathogenesis of water and sodium retention in cirrhosis. Kidney Int Suppl, 1997; 59(3)∶S43.
23.	Roberts LR, Kamath PS. Ascites and hepatorenal syndrome: pathophysiology and management. Mayo Clin Proc, 1996; 71(4)∶9.
24.	Casadevall M, Panes J, Pigue JM, et al. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portalhypertensive anesthetized rats. Hepatology, 1993; 18(3)∶628.
25.	Tanoue K, Ohta M, Tarnawski AS, et al. Portal hypertension activities the nitric oxide synthase genes in the esophageal mucosa of rats. Gastroenterology, 1996; 110(2)∶549.
26.	Ohta M, Tanoue K, Tarnaski AS, et al. Overexpressed nitric oxide synthase in portalhypertensive stomach of rat: a key to increased susceptibility to damage? Gastroenterology, 1997; 112(6)∶1920.

1. 梅小君，顾正中.一氧化氮对脑血流的调节.生理科学进展， 1995； 26(1)∶35.
2. Gadano AC, Sogni P, Yang S, et al. Endothelial calciumcalmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivily of portal hypertensive rats. J Hepatol, 1997; 26(3)∶678.
3. Cahill PA, Foster C, Redmond EM, et al. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology, 1995; 22(2)∶598.
4. Pilette C, Moreau R, Sogni P, et al. Haemodynamic and hormonal responses to longterm inhibition of nitric oxide synthesis in rats with portal hypertension. Eur J Pharmacol, 1996; 312(1)∶63.
5. Garc J, Atucha NM, Groszmann RJ. Renal response to methoxamine in portal hypertensive rats: role of prostaglandins and nitric oxide. J Hepatol, 1996; 25(2)∶206.
6. Michielsen PP, Boeckxstaens GE, Sys SU, et al. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in longterm portal vein ligated rats. J Hepatol. 1995; 23(3)∶341.
7. Pizcuta P, Pique JM, Fernandez M, et al. Modulation of the hyperdynamic circulation of cirrhosis rats by nitric oxide inhibition. Gastroenterology, 1992; 103(2)∶1909.
8. Pilette C, Kirstetter P, Sogni P, et al. Dosedependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hyportension in conscious rats. J Gastroenterol Hepatol, 1996; 11(1)∶1.
9. Sieber CC, Lee FY, Groszmann RJ. Longterm octreotide treatment prevents hyporeactivity in portal hypertensive rats. Hepatology, 1996; 23(5)∶1218.
10. Cawley T, Breslin E, Geraghty J, et al. Investigations of the function of the vascular endothelium in portal hypertensive rats. Pharmacology, 1995; 51(6)∶381.
11. Hori N, Takahashi H, Okanoue T, et al. Augmented endogenous nitric oxide production in partial portal vein ligated rats. Clin Exp Pharmacol Physiol, 1995; 22(8)∶506.
12. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vascular in mesenteric vessels of portal hypertensive rats. Gastroenterology, 1992; 103(1)∶235.
13. Karatapanis S, McCornick PA, Kaked S, et al. Alteration in vascular reactivity in isolated aortic rings from portal veinconstricted rats. Hepatology, 1994; 20(6)∶1516.
14. Cahill PA, Redmond EM, Hodges R, et al. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol, 1996; 25(3)∶370.
15. Wu Y, Burns RC, Sitzmann JV. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. Hepatology, 1993; 18(6)∶1416.
16. Sogni P, Moreau R, Ohsuga M, et al. Evidence for normal nitric oxidemediated vasodilator tone in conscious rats with cirrhosis. Hepatology, 1992; 16(4)∶980.
17. Iwata F, Joh T, Kawai T, et al. Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats. Am J Physiol, 1992; 263(4)∶G149.
18. Mosca P, Lee FY, Kaumann AJ, et al. Pharmacology of portalsystemic collaterals in portal hypertensive rats: role of endothelium. Am J Physiol, 1992; 263(4 pt 1)∶G544.
19. Lee FY, Wang SS, Tsai YT, et al. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats. J Hepatol, 1997; 26(3)∶687.
20. Michielsen PP, Pelckmans A. Haemodynamic changes in portal hypertension: new insights in the pathogenesis and clinical implications. Acta Gastroenterol Belg, 1994; 57(2)∶194.
21. Lee FY, Colombato LA, Albillos A, et al. Administration of N omeganitroLarginine ameliorates portalsystemic shunting in portalhypertensive rats. Gastroenterology, 1993; 105(5)∶1464.
22. Martin PY, Schrier RW. Pathogenesis of water and sodium retention in cirrhosis. Kidney Int Suppl, 1997; 59(3)∶S43.
23. Roberts LR, Kamath PS. Ascites and hepatorenal syndrome: pathophysiology and management. Mayo Clin Proc, 1996; 71(4)∶9.
24. Casadevall M, Panes J, Pigue JM, et al. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portalhypertensive anesthetized rats. Hepatology, 1993; 18(3)∶628.
25. Tanoue K, Ohta M, Tarnawski AS, et al. Portal hypertension activities the nitric oxide synthase genes in the esophageal mucosa of rats. Gastroenterology, 1996; 110(2)∶549.
26. Ohta M, Tanoue K, Tarnaski AS, et al. Overexpressed nitric oxide synthase in portalhypertensive stomach of rat: a key to increased susceptibility to damage? Gastroenterology, 1997; 112(6)∶1920.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

一氧化氮与门静脉高压症

Abstract Full text Figures/Tables Video References Cited by

Format

Content